Should people with psychosis be supported in choosing cognitive therapy as an alternative to antipsychotic medication: A commentary on current evidence

Alvarez-Jimenez, 2008, Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials, Br. J. Psychiatry, 193, 101, 10.1192/bjp.bp.107.042853 Artaloytia, 2006, Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers, Am. J. Psychiatry, 163, 488, 10.1176/appi.ajp.163.3.488 Bola, 2012, Antipsychotic medication for early-episode schizophrenia, Schizophr. Bull., 38, 23, 10.1093/schbul/sbr167 Byrne, 2010, Priorities & preferences for the outcomes of treatment of psychosis: a service user perspective, Psychosis, 2, 210, 10.1080/17522430903456913 Carter, 2017, Causal beliefs in people experiencing psychosis: the relationship to treatment accessed and the perceived helpfulness of treatment, Psychol. Psychother. Theory Res. Pract. Christodoulides, 2008, Cognitive behaviour therapy in patients with schizophrenia who are not prescribed antipsychotic medication: a case series, Psychol. Psychother. Theory Res. Pract., 81, 199, 10.1348/147608308X278295 Correll, 2009, Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents, JAMA, 302, 1765, 10.1001/jama.2009.1549 Dixon, 2010, The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements, Schizophr. Bull., 36, 48, 10.1093/schbul/sbp115 Faber, 2012, The effects of guided discontinuation of antipsychotics on neurocognition in first onset psychosis, Eur. Psychiatry, 27, 275, 10.1016/j.eurpsy.2011.02.003 Foley, 2011, Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis, Arch. Gen. Psychiatry, 68, 609, 10.1001/archgenpsychiatry.2011.2 Furukawa, 2015, Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies, JAMA Psychiat., 72, 14, 10.1001/jamapsychiatry.2014.2127 Galletly, 2016, Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders, Aust. N. Z. J. Psychiatry, 50, 410, 10.1177/0004867416641195 Goldsmith, 2015, Psychological treatments for early psychosis can be beneficial or harmful, depending on the therapeutic alliance: an instrumental variable analysis, Psychol. Med., 45, 2365, 10.1017/S003329171500032X Haddad, 2007, Adverse effects of atypical antipsychotics: differential risk and clinical implications, CNS Drugs, 21, 911, 10.2165/00023210-200721110-00004 Harrow, 2012, Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study, Psychol. Med., 42, 2145, 10.1017/S0033291712000220 Ho, 2011, Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia, Arch. Gen. Psychiatry, 68, 128, 10.1001/archgenpsychiatry.2010.199 Howes, 2014, Cognitive therapy: at last an alternative to antipsychotics?, Lancet, 383, 1364, 10.1016/S0140-6736(13)62569-6 Jauhar, 2014, Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias, Br. J. Psychiatry, 204, 20, 10.1192/bjp.bp.112.116285 Kimhy, 2013, Cognitive behavioral therapy for psychosis – training practices and dissemination in the United States, Psychosis, 5, 296, 10.1080/17522439.2012.704932 Kinon, 2009, Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia, Neuropsychopharmacology, 35, 581, 10.1038/npp.2009.164 Kryzhanovskaya, 2012, Comparison of long-term (at least 24 weeks) weight gain and metabolic changes between adolescents and adults treated with olanzapine, J. Child Adolesc. Psychopharmacol., 22, 157, 10.1089/cap.2010.0020 Lacro, 2002, Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature, J. Clin. Psychiatry, 63, 892, 10.4088/JCP.v63n1007 Law, 2017, A pilot randomised controlled trial comparing antipsychotic medication, to cognitive behavioural therapy to a combination of both in people with psychosis: rationale, study design and baseline data of the COMPARE trial, Psychosis, 9, 193, 10.1080/17522439.2017.1316302 Leamy, 2011, Conceptual framework for personal recovery in mental health: systematic review and narrative synthesis, Br. J. Psychiatry, 199, 445, 10.1192/bjp.bp.110.083733 Leucht, 2009, How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials, Mol. Psychiatry, 14, 429, 10.1038/sj.mp.4002136 Leucht, 2012, Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis, Lancet, 379, 2063, 10.1016/S0140-6736(12)60239-6 Leucht, 2013, Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis, Lancet, S0140-6736, 60733 Leucht, 2017, Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors, Am. J. Psychiatry, 174, 927, 10.1176/appi.ajp.2017.16121358 Lincoln, 2016, The impact of negative treatment experiences on persistent refusal of antipsychotics, Compr. Psychiatry, 70, 165, 10.1016/j.comppsych.2016.07.009 Marques, 2011, The different trajectories of antipsychotic response: antipsychotics versus placebo, Psychol. Med., 41, 1481, 10.1017/S0033291710002035 Mehl, 2015, Does cognitive behavior therapy for psychosis (CBTp) show a sustainable effect on delusions? A meta-analysis, Front. Psychol., 6 Moncrieff, 2010, A systematic review of the effects of antipsychotic drugs on brain volume, Psychol. Med., 40, 1409, 10.1017/S0033291709992297 Moncrieff, 2009, The subjective experience of taking antipsychotic medication: a content analysis of Internet data, Acta Psychiatr. Scand., 120, 102, 10.1111/j.1600-0447.2009.01356.x Moritz, 2017, The customer is always right? Subjective target symptoms and treatment preferences in patients with psychosis, Eur. Arch. Psychiatry Clin. Neurosci., 267, 335, 10.1007/s00406-016-0694-5 Morrison, 1994, Cognitive behaviour therapy for auditory hallucinations without concurrent medication: a single case, Behav. Cogn. Psychother., 22, 259, 10.1017/S1352465800013126 Morrison, 2001, Cognitive therapy for auditory hallucinations as an alternative to antipsychotic medication: a case series, Clin. Psychol. Psychother., 8, 136, 10.1002/cpp.269 Morrison, 2012, Cognitive therapy for people with a schizophrenia spectrum diagnosis not taking antipsychotic medication: an exploratory trial, Psychol. Med., 42, 1049, 10.1017/S0033291711001899 Morrison, 2013, Impact of cognitive therapy on internalised stigma in people with at-risk mental states, Br. J. Psychiatry, 203, 140, 10.1192/bjp.bp.112.123703 Morrison, 2014, Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial, Lancet, 10.1016/S0140-6736(13)62246-1 Morrison, 2018, Comparing antipsychotic medication to cognitive behavioural therapy to a combination of both in people with psychosis: a pilot and feasibility randomised controlled trial, Lancet Psychiatry, 10.1016/S2215-0366(18)30096-8 Murray, 2016, Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?, Br. J. Psychiatry, 209, 361, 10.1192/bjp.bp.116.182683 National Institute for Clinical Excellence, 2013 National Institute for Health and Care Excellence, 2014 Ray, 2009, Atypical antipsychotic drugs and the risk of sudden cardiac death, N. Engl. J. Med., 360, 225, 10.1056/NEJMoa0806994 Spencer, 2017, Diversity or disarray? A systematic review of decision-making capacity for treatment and research in schizophrenia and other non-affective psychoses, Psychol. Med., 1 Stovell, 2016, Shared treatment decision-making and empowerment-related outcomes in psychosis: systematic review and meta-analysis, Br. J. Psychiatry, 209, 23, 10.1192/bjp.bp.114.158931 Szymczynska, 2017, Attrition in trials evaluating complex interventions for schizophrenia: systematic review and meta-analysis, J. Psychiatr. Res., 90, 67, 10.1016/j.jpsychires.2017.02.009 Taylor, 2015, NICE CG178 psychosis and schizophrenia in adults: treatment and management – an evidence-based guideline?, Br. J. Psychiatry, 206, 357, 10.1192/bjp.bp.114.155945 Teff, 2013, Antipsychotic-induced insulin resistance and postprandial hormonal dysregulation independent of weight gain or psychiatric disease, Diabetes, 62, 3232, 10.2337/db13-0430 The Schizophrenia Commission, 2012 van der Gaag, 2014, The effects of individually tailored formulation-based cognitive behavioural therapy in auditory hallucinations and delusions: a meta-analysis, Schizophr. Res., 156, 30, 10.1016/j.schres.2014.03.016 Vita, 2015, The effect of antipsychotic treatment on cortical gray matter changes in schizophrenia: does the class matter? A meta-analysis and meta-regression of longitudinal magnetic resonance imaging studies, Biol. Psychiatry, 78, 403, 10.1016/j.biopsych.2015.02.008 Wade, 2017, A systematic review of service-user reasons for adherence and nonadherence to neuroleptic medication in psychosis, Clin. Psychol. Rev., 51, 75, 10.1016/j.cpr.2016.10.009 Warner, 2006 Wood, 2015, Individual cognitive behavioural therapy for psychosis (CBTp): a systematic review of qualitative literature, Behav. Cogn. Psychother., 43, 285, 10.1017/S1352465813000970 Wunderink, 2013, JAMA Psychiat., 70, 913, 10.1001/jamapsychiatry.2013.19